Literature DB >> 23095415

Extracorporeal liver support.

Pamela Leckie1, Andrew Davenport, Rajiv Jalan.   

Abstract

Mortality of patients with liver failure remains unacceptably high. As the liver has an enormous potential to regenerate, extracorporeal liver support devices may allow patients with liver failure to be bridged to recovery. Alternatively, liver assist may allow patients with advanced liver disease to be managed until a suitable organ for transplant is available. Current approaches to liver support include the use of biological devices that contain hepatocytes and those that function as detoxification devices, and artificial liver support systems. This review describes the current state of the art and existing data on the use of these devices to treat patients with liver failure.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23095415     DOI: 10.1159/000342065

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  4 in total

1.  Effects of bone marrow MSCs transfected with sRAGE on the intervention of HMGB1 induced immuno-inflammatory reaction.

Authors:  Jun Wang; Hao Wang; Jiong Shi; Yitao Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Newly established human liver cell line: a potential cell source for the bioartificial liver in the future.

Authors:  Hongling Liu; Shaoli You; Yihui Rong; Yichen Wu; Bing Zhu; Zhihong Wan; Wanshu Liu; Panyong Mao; Shaojie Xin
Journal:  Hum Cell       Date:  2013-12       Impact factor: 4.174

3.  Bio-Pick, Place, and Perfuse: A New Instrument for Three-Dimensional Tissue Engineering.

Authors:  Andrew M Blakely; Kali L Manning; Anubhav Tripathi; Jeffrey R Morgan
Journal:  Tissue Eng Part C Methods       Date:  2015-02-09       Impact factor: 3.056

4.  Prometheus therapy for the treatment of acute liver failure in patients after cardiac surgery.

Authors:  Ekaterina Komardina; Michael Yaroustovsky; Marina Abramyan; Marina Plyushch
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.